首页> 外文期刊>The Canadian journal of cardiology >Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation With Acute Refractory Cardiogenic Shock
【24h】

Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation With Acute Refractory Cardiogenic Shock

机译:经截管主动脉瓣膜置换严重的主动脉反冲与急性难治性心肌休克

获取原文
获取原文并翻译 | 示例
           

摘要

From January 2013 to January 2017, 686 consecutive patients were referred to our centre for transcatheter aortic valve replacement, including 5 subjects with severe aortic regurgitation and acute refractory cardiogenic shock. These patients were contraindicated for surgical treatment by the heart team because of high surgical risk (median logistic EuroSCORE: 74.6/Society of Thoracic Surgeons score: 37.9). The success rate of valve implantation was 100% through transfemoral access with self-expandable devices. The observed 30-day mortality rate was 20%. Hence, the transcatheter aortic valve replacement procedure might represent a successful and life-saving intervention for treatment of patients with severe aortic regurgitation who present with acute refractory cardiogenic shock.
机译:从2013年1月到2017年1月,686名连续患者被转介到我们的中心接受经导管主动脉瓣置换术,包括5名患有严重主动脉瓣反流和急性难治性心源性休克的受试者。这些患者因手术风险高而被心脏小组禁止进行手术治疗(中位逻辑欧洲评分:74.6/胸科医师学会评分:37.9)。采用自膨胀装置经股动脉途径植入瓣膜的成功率为100%。观察到的30天死亡率为20%。因此,对于出现急性难治性心源性休克的严重主动脉瓣关闭不全患者,经导管主动脉瓣置换术可能是一种成功的、挽救生命的干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号